Внесок користувача
- 18:39, 13 січня 2017 (різн. • історія) . . (+61) . . м Storage and use of all tissues included in the work presented here was carried out in accordance with the Helsinki declaration and approved by the Tayside Committee on Medical Research Ethics (поточна)
- 18:37, 13 січня 2017 (різн. • історія) . . (+3826) . . Н Storage and use of all tissues included in the work presented here was carried out in accordance with the Helsinki declaration and approved by the Tayside Committee on Medical Research Ethics (Створена сторінка: Storage and use of all tissues integrated in the operate introduced listed here was carried out in accordance with the Helsinki declaration and authorized by th...)
- 00:12, 12 січня 2017 (різн. • історія) . . (+75) . . м The E protein is a major target in the immune response to DENV, and structural analysis demonstrated that some E epitopes are preferentially exposed in immature virions (поточна)
- 00:08, 12 січня 2017 (різн. • історія) . . (+3710) . . Н The E protein is a major target in the immune response to DENV, and structural analysis demonstrated that some E epitopes are preferentially exposed in immature virions (Створена сторінка: We lately observed that a weakly neutralizing West Nile virus (WNV) fusion loop antibody has the capacity to render immature WNV particles infectious [thirty]....)
- 16:27, 11 січня 2017 (різн. • історія) . . (+3858) . . Н Analogous to virus particle maturation during egress, the internalized antibody-opsonized immature virus particles are processed by cellular furin present in the endocytic pathway, thereby allowing virus infection (Створена сторінка: Dengue virus (DENV) is the foremost trigger of mosquito-borne viral ailment in the world. It is estimated that more than 50 million DENV bacterial infections oc...) (поточна)
- 05:08, 10 січня 2017 (різн. • історія) . . (+75) . . м However, molecular interventions that increase PGRN production or secretion from the remaining wildtype allele are a promising therapeutic strategy for FTLD caused by PGRN deficiency (поточна)
- 05:07, 10 січня 2017 (різн. • історія) . . (+3546) . . Н However, molecular interventions that increase PGRN production or secretion from the remaining wildtype allele are a promising therapeutic strategy for FTLD caused by PGRN deficiency (Створена сторінка: Data are proven as indicate +/2 SD.For pull down experiments GST or GST-TRN-SR2 ended up absorbed on glutathione-agarose for 1 hr adopted by addition of purifie...)